NYSE · VTR
Real Estate · REIT - Healthcare Facilities
$85.86
Up+$1.00 (+1.18%)
Updated Oct 19, 2026, 4:39 AM
SID Score
5.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · VTR
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
VTR closed at $85.86 after 20 trading sessions, down 1.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $85.10 | $86.04 | $84.555 | $85.86 | 3.85M |
| Oct 15, 2026 | $85.98 | $86.36 | $84.565 | $84.86 | 4.25M |
| Oct 14, 2026 | $84.18 | $85.40 | $83.26 | $84.31 | 3.94M |
| Oct 13, 2026 | $84.41 | $84.43 | $83.06 | $83.85 | 4.04M |
| Oct 12, 2026 | $82.06 | $83.56 | $81.71 | $83.54 | 4.81M |
| Oct 9, 2026 | $81.72 | $82.935 | $81.33 | $82.04 | 4.09M |
| Oct 8, 2026 | $80.11 | $82.245 | $79.85 | $81.76 | 4.59M |
| Oct 7, 2026 | $82.13 | $82.305 | $79.93 | $80.04 | 4.18M |
| Oct 6, 2026 | $81.48 | $82.065 | $80.77 | $81.86 | 4.03M |
| Oct 5, 2026 | $83.95 | $84.05 | $81.13 | $81.36 | 7.57M |
| Oct 2, 2026 | $84.40 | $84.81 | $83.23 | $84.01 | 2.95M |
| Oct 1, 2026 | $84.70 | $84.87 | $83.325 | $83.73 | 3.09M |
| Sep 30, 2026 | $86.86 | $87.22 | $84.96 | $85.02 | 2.9M |
| Sep 29, 2026 | $86.43 | $87.20 | $86.09 | $86.91 | 2.38M |
| Sep 28, 2026 | $86.88 | $87.87 | $86.51 | $87.04 | 2.17M |
| Sep 25, 2026 | $87.06 | $87.06 | $85.62 | $86.59 | 2.42M |
| Sep 24, 2026 | $87.20 | $88.49 | $86.725 | $86.83 | 3.13M |
| Sep 23, 2026 | $86.35 | $87.09 | $85.895 | $86.64 | 2.74M |
| Sep 22, 2026 | $86.25 | $87.28 | $86.25 | $86.86 | 5.94M |
| Sep 21, 2026 | $86.77 | $87.81 | $86.55 | $87.03 | 5.43M |
The latest Smart Investors Daily articles mentioning VTR.
Company
Market Activity
Research & News
VTR research
Company profile and research snapshot.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | Barclays | Equal-Weight | — |
| Sep 21, 2026 | Evercore ISI Group | Outperform | — |
| Sep 2, 2026 | Scotiabank | Sector Perform | — |
| Sep 1, 2026 | Wells Fargo | Overweight | — |
| Aug 31, 2026 | Barclays | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Oct 17, 2026
Both senior housing giants raised dividends and beat expectations this quarter, but retirees choosing between them face a real tradeoff that comes down to how soon you need the money and how much risk you can stomach on the balance sheet.
Yahoo · Oct 13, 2026
Guinness Global Investors recently released its “Global Real Assets Fund” August 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 0.8% in July, underperforming the MSCI World Core Infrastructure Index’s 1.8% gain by 1 percentage point, but remained ahead year to date, returning 11.1% versus 10.9% for the benchmark, […]
Benzinga · Oct 13, 2026
Barclays analyst Richard Hightower maintains Ventas (NYSE:VTR) with a Equal-Weight and lowers the price target from $102 to $91.
Yahoo · Oct 13, 2026
Ventas, Inc. (NYSE:VTR) closed at $82.04 on October 9. The stock has returned -2.8% during the last six months, compared to a 24.3% return for the Insider Monkey Billionaire Index and 15.1% for State Street SPDR S&P 500 ETF Trust. Ventas is paid to house people who are living longer, which is the one demographic […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VTR.
